Clinical Trial Update: Safety Study of Renal Function in Patients With Chronic Kidney Failure Taking Lumiracoxib or Diclofenac for Arthralgia [Phase 2]

View source ↗

Summary

A Phase 2 safety study evaluating renal function in patients with chronic kidney disease taking lumiracoxib or diclofenac for arthralgia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthralgia
• Chronic Kidney Disease

Drugs mentioned

• Diclofenac (diclofenac)
• Lumiracoxib (Lumiracoxib)

Snippet

Sponsor: Hospital Central Sur de Pemex | Conditions: Kidney Failure, Chronic, Arthralgia | Phase 2 | Status: TERMINATED